enoxacin has been researched along with Congenital Zika Syndrome in 2 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM | 1 |
Yasgar, A | 1 |
Teramoto, T | 1 |
Lee, MH | 1 |
Dorjsuren, D | 1 |
Eastman, RT | 1 |
Malik, N | 1 |
Zakharov, AV | 1 |
Li, W | 1 |
Bachani, M | 1 |
Brimacombe, K | 1 |
Steiner, JP | 1 |
Hall, MD | 1 |
Balasubramanian, A | 1 |
Jadhav, A | 1 |
Padmanabhan, R | 1 |
Simeonov, A | 1 |
Nath, A | 1 |
Xu, YP | 1 |
Qiu, Y | 1 |
Zhang, B | 1 |
Chen, G | 1 |
Chen, Q | 1 |
Wang, M | 1 |
Mo, F | 1 |
Xu, J | 1 |
Wu, J | 1 |
Zhang, RR | 1 |
Cheng, ML | 1 |
Zhang, NN | 1 |
Lyu, B | 1 |
Zhu, WL | 1 |
Wu, MH | 1 |
Ye, Q | 1 |
Zhang, D | 1 |
Man, JH | 1 |
Li, XF | 1 |
Cui, J | 1 |
Xu, Z | 1 |
Hu, B | 1 |
Zhou, X | 1 |
Qin, CF | 1 |
2 other studies available for enoxacin and Congenital Zika Syndrome
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids.
Topics: Animals; Antiviral Agents; Brain; Cell Line; Enoxacin; Humans; Immunity, Innate; Neural Stem Cells; | 2019 |